Holocene Advisors’s DexCom DXCM Stock Holding History

Holocene Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-960,000	Closed	-$98.9M	–	773
2020 Q3	$98.9M	Buy	+960,000	New	+$100M	0.75%	33

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Holocene Advisors's DXCM Position: Q4 2025 in Review

Holocene Advisors sold out of DexCom (DXCM) in Q4 2025, closing a stake of 2,436,672 shares — an estimated $164M sold.

Holocene Advisors first reported a position in DXCM in Q4 2017 and held it in 26 quarters. The position peaked at $241M in Q3 2023. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Holocene Advisors reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Holocene Advisors sold 2,436,672 DexCom shares in Q4 2025, an estimated $164M.
Holocene Advisors first reported a position in DexCom in Q4 2017 and held it in 26 quarters.
Holocene Advisors's DexCom position peaked at $241M in Q3 2023.
920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Holocene Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.